Lexicon Pharmaceuticals, Inc. Reports 2008 Second Quarter Financial Results
THE WOODLANDS, Texas, July 29, 2008 (PRIME NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three and six months ended June 30, 2008.